Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS
Seiten
1991
John Wiley & Sons Inc (Verlag)
978-0-471-56880-3 (ISBN)
John Wiley & Sons Inc (Verlag)
978-0-471-56880-3 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Intends to inform clinical investigators and biomedical researchers of the applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. The book discusses experimental clinical applications and therapeutic implications.
This study is designed to inform clinical investigators and biomedical researchers of the range of possible applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. These new DNA and RNA agents are intended to stop the growth of cancerous cells or to halt the production of HIV infected cells. The book details the rapid progress of this new technology from its theoretical stage to its current position at the verge of experimental clinical applications with provocative discussions of the therapeutic implications of the basic research.
This study is designed to inform clinical investigators and biomedical researchers of the range of possible applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. These new DNA and RNA agents are intended to stop the growth of cancerous cells or to halt the production of HIV infected cells. The book details the rapid progress of this new technology from its theoretical stage to its current position at the verge of experimental clinical applications with provocative discussions of the therapeutic implications of the basic research.
Biologic and Therapeutic Implications of Antisense Inhibition of Gene Expression; Oligonucleotide Base Hybridization as a Modulator of Genetic Message Readout; Novel Antisense Derivatives: Antisense DNA Intercalators, Cleavers and Alkylators; Antisense DNA Treatment of HL-60 Promyelocytic Leukemia Cells.
Erscheint lt. Verlag | 5.11.1991 |
---|---|
Zusatzinfo | Ill. |
Verlagsort | New York |
Sprache | englisch |
Maße | 184 x 262 mm |
Gewicht | 822 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
ISBN-10 | 0-471-56880-5 / 0471568805 |
ISBN-13 | 978-0-471-56880-3 / 9780471568803 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller
Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
21,99 €
Die revolutionäre Medizin von morgen (Lifespan)
Buch | Softcover (2020)
DuMont Buchverlag
16,00 €